When beta-blocker monotherapy is insufficient in controlling angina, NICE guidelines suggest incorporating a calcium channel blocker. However, verapamil is not recommended while taking a beta-blocker, and diltiazem should be used with caution due to the possibility of bradycardia. The initial dosage for isosorbide mononitrate is twice daily at 10 mg.

Angina pectoris can be managed through lifestyle changes, medication, percutaneous coronary intervention, and surgery. In 2011, NICE released guidelines for the management of stable angina. Medication is an important aspect of treatment, and all patients should receive aspirin and a statin unless there are contraindications. Sublingual glyceryl trinitrate can be used to abort angina attacks. NICE recommends using either a beta-blocker or a calcium channel blocker as first-line treatment, depending on the patient’s comorbidities, contraindications, and preferences. If a calcium channel blocker is used as monotherapy, a rate-limiting one such as verapamil or diltiazem should be used. If used in combination with a beta-blocker, a longer-acting dihydropyridine calcium channel blocker like amlodipine or modified-release nifedipine should be used. Beta-blockers should not be prescribed concurrently with verapamil due to the risk of complete heart block. If initial treatment is ineffective, medication should be increased to the maximum tolerated dose. If a patient is still symptomatic after monotherapy with a beta-blocker, a calcium channel blocker can be added, and vice versa. If a patient cannot tolerate the addition of a calcium channel blocker or a beta-blocker, long-acting nitrate, ivabradine, nicorandil, or ranolazine can be considered. If a patient is taking both a beta-blocker and a calcium-channel blocker, a third drug should only be added while awaiting assessment for PCI or CABG.

Nitrate tolerance is a common issue for patients who take nitrates, leading to reduced efficacy. NICE advises patients who take standard-release isosorbide mononitrate to use an asymmetric dosing interval to maintain a daily nitrate-free time of 10-14 hours to minimize the development of nitrate tolerance. However, this effect is not seen in patients who take once-daily modified-release isosorbide mononitrate.

Fraser Guidelines for Young People’s Competence to Consent to Contraceptive Advice or Treatment

The Fraser guidelines provide a framework for healthcare professionals to determine whether a young person is competent to consent to contraceptive advice or treatment.

According to the guidelines, a young person is considered competent if they understand the doctor’s advice, cannot be persuaded to inform their parents or allow the doctor to inform the parents, are likely to start or continue having sexual intercourse with or without contraceptive treatment, their physical or mental health (or both) are likely to deteriorate if contraceptive advice/treatment is not given, and their best interests require the doctor to give advice/treatment without parental consent.

It is important to follow these guidelines as failure to provide contraceptive advice or treatment can put young people at risk of physical and mental harm, including unwanted pregnancies. In the UK, statistics suggest that about 30-40% of young people have had sexual intercourse by the time they are 16. Therefore, it is crucial for healthcare professionals to assess young people’s competence to consent to contraceptive advice or treatment and provide appropriate care.

Managing Diarrhoea and Vomiting in Children

Diarrhoea and vomiting are common in young children, with rotavirus being the most common cause of gastroenteritis in the UK. The 2009 NICE guidelines provide recommendations for managing these symptoms in children. Diarrhoea typically lasts for 5-7 days and stops within 2 weeks, while vomiting usually lasts for 1-2 days and stops within 3 days. When assessing hydration status, NICE suggests using normal, dehydrated, or shocked categories instead of the traditional mild, moderate, or severe categories.

Children younger than 1 year, especially those younger than 6 months, infants who were of low birth weight, and those who have passed six or more diarrhoeal stools in the past 24 hours or vomited three times or more in the past 24 hours are at an increased risk of dehydration. Infants who have stopped breastfeeding during the illness and children with signs of malnutrition are also at risk. Features suggestive of hypernatraemic dehydration include jittery movements, increased muscle tone, hyperreflexia, convulsions, and drowsiness or coma.

If clinical shock is suspected, children should be admitted for intravenous rehydration. For children with no evidence of dehydration, continue breastfeeding and other milk feeds, encourage fluid intake, and discourage fruit juices and carbonated drinks. If dehydration is suspected, give 50 ml/kg low osmolarity oral rehydration solution (ORS) solution over 4 hours, plus ORS solution for maintenance, often and in small amounts. It is also important to continue breastfeeding and consider supplementing with usual fluids (including milk feeds or water, but not fruit juices or carbonated drinks). Stool culture should be done in certain situations, such as when septicaemia is suspected or there is blood and/or mucous in the stool, or when the child is immunocompromised.

Management of Suspected Pulmonary Embolism

When a patient presents with sudden onset breathlessness, haemoptysis, pleuritic pain, hypotension, tachycardia, increased respiratory rate, and low oxygen saturations, pulmonary embolism (PE) should be suspected. It is important to note any risk factors that may increase the likelihood of an embolism. The absence of signs of deep vein thrombosis doesn’t exclude the possibility of a PE.

Immediate admission to the hospital should be arranged for patients with suspected PE who have signs of haemodynamic instability or are pregnant or have given birth within the past 6 weeks. Management should not be delayed for results of a chest X-ray or ECG. Therefore, the correct option is to arrange immediate transfer to the hospital by blue light. Prescribing a non-steroidal anti-inflammatory drug fails to appreciate the possibility of pulmonary embolism and should not be selected.

In summary, prompt recognition and management of suspected PE is crucial to prevent morbidity and mortality.

The temperature range for a vaccination refrigerator should be between +2ºC and +8ºC.

Other Aspects of Immunisation

Consent is an important aspect of immunisation, and the Greenbook provides useful information on this topic. Written consent is not required, and a person with parental responsibility may give consent on behalf of a child who is not competent to give or withhold consent. Parental responsibility is defined by the Children Act 1989, and unmarried fathers can acquire it if they are named on the child’s birth certificate. If parents disagree, immunisation cannot go ahead without specific court approval. A person with parental responsibility doesn’t need to be present at the time of immunisation, but the healthcare provider must be satisfied that consent has been given in advance.

Vaccine storage is also crucial to ensure the effectiveness of immunisation. Vaccines should be stored in a fridge at +2ºC to +8ºC and kept in their original packaging to protect them from UV light. The temperature of the refrigerator should be monitored using a maximum-minimum thermometer and recorded daily. Ordinary domestic refrigerators should not be used, and surgeries should keep no more than 2 to 4 weeks’ supply of vaccines at any time. By following these guidelines, healthcare providers can ensure that vaccines are stored properly and administered safely to patients.

The bullous form of lichen planus is an exceptionally uncommon occurrence.

Bullous Disorders: Causes and Types

Bullous disorders are characterized by the formation of fluid-filled blisters or bullae on the skin. These can be caused by a variety of factors, including congenital conditions like epidermolysis bullosa, autoimmune diseases like bullous pemphigoid and pemphigus, insect bites, trauma or friction, and certain medications such as barbiturates and furosemide.

Epidermolysis bullosa is a rare genetic disorder that affects the skin’s ability to adhere to the underlying tissue, leading to the formation of blisters and sores. Autoimmune bullous disorders occur when the immune system mistakenly attacks proteins in the skin, causing blistering and inflammation. Insect bites can also cause bullae to form, as can trauma or friction from activities like sports or manual labor.

Certain medications can also cause bullous disorders as a side effect. Barbiturates, for example, have been known to cause blistering and skin rashes in some people. Furosemide, a diuretic used to treat high blood pressure and edema, can also cause bullae to form in some cases.

Overall, bullous disorders can be caused by a variety of factors and can range from mild to severe. Treatment options depend on the underlying cause and may include medications, wound care, and lifestyle modifications.

Perforated Tympanic Membrane: Causes and Management

A perforated tympanic membrane, also known as a ruptured eardrum, is often caused by an infection but can also result from barotrauma or direct trauma. This condition can lead to hearing loss and increase the risk of otitis media.

In most cases, no treatment is necessary as the tympanic membrane will typically heal on its own within 6-8 weeks. However, it is important to avoid getting water in the ear during this time. Antibiotics may be prescribed if the perforation occurs after an episode of acute otitis media. This approach is supported by the 2008 Respiratory Tract Infection Guidelines from NICE.

If the tympanic membrane doesn’t heal by itself, myringoplasty may be performed. This surgical procedure involves repairing the perforation with a graft of tissue taken from another part of the body. With proper management, a perforated tympanic membrane can be successfully treated and hearing can be restored.

Understanding the Possible Eye Conditions Caused by Corticosteroid Treatment

Corticosteroid treatment can cause various eye conditions, including dry eyes, cataracts, and glaucoma. Dry eye syndrome is characterized by a burning or gritty sensation, dryness, intermittent blurring of vision, redness, itching, and photosensitivity. Cataracts caused by corticosteroids are typically posterior and subcapsular, leading to gradually progressive blurring of vision. Glaucoma may also occur due to raised intraocular pressure, resulting in optic nerve damage and peripheral vision loss. However, any optic nerve damage is irreversible. In contrast, corticosteroid eye drops may be used to manage inflammatory eye disorders associated with dry eyes. Fluctuating blood sugar levels caused by corticosteroids can also result in osmotic swelling of the lens, leading to intermittent blurring of vision. Finally, a transient ischaemic attack may cause acute transient loss of vision or transient diplopia, but it is not related to corticosteroid treatment.

Erectile dysfunction (ED) is a condition where a person is unable to achieve or maintain an erection that is sufficient for satisfactory sexual performance. The causes of ED can be categorized into organic, psychogenic, or mixed, and can also be caused by certain medications.

Symptoms that indicate a psychogenic cause of ED include a sudden onset, early loss of erection, self-stimulated or waking erections, premature ejaculation or inability to ejaculate, relationship problems or changes, major life events, and psychological issues.

On the other hand, symptoms that suggest an organic cause of ED include a gradual onset and normal ejaculation.

Erectile dysfunction (ED) is a condition where a man is unable to achieve or maintain an erection that is sufficient for sexual performance. It is not a disease but a symptom that can be caused by organic, psychogenic, or mixed factors. It is important to differentiate between the causes of ED, with factors such as a gradual onset of symptoms and lack of tumescence favoring an organic cause, while sudden onset of symptoms and decreased libido favoring a psychogenic cause. Risk factors for ED include cardiovascular disease, alcohol use, and certain medications.

To assess for ED, it is recommended to measure lipid and fasting glucose serum levels to calculate cardiovascular risk. Free testosterone should also be measured in the morning, and if low or borderline, further assessment may be needed. PDE-5 inhibitors, such as sildenafil, are the first-line treatment for ED and should be prescribed to all patients regardless of the cause. Vacuum erection devices can be used as an alternative for those who cannot or will not take PDE-5 inhibitors. Referral to urology may be appropriate for young men who have always had difficulty achieving an erection, and those who cycle for more than three hours per week should be advised to stop.

Pyelonephritis is most commonly caused by E. coli, with young females having the highest incidence. Given the patient’s symptoms and previous T1DM diagnosis, this is a likely diagnosis. While other organisms can also cause pyelonephritis, any that can ascend up the genitourinary tract, E. coli is the most frequent culprit.

Understanding Acute Pyelonephritis

Acute pyelonephritis is a condition that is commonly caused by an ascending infection, usually E. coli from the lower urinary tract. However, it can also be caused by the spread of infection through the bloodstream, leading to sepsis. The clinical features of acute pyelonephritis include fever, rigors, loin pain, nausea/vomiting, and symptoms of cystitis such as dysuria and urinary frequency.

To diagnose acute pyelonephritis, patients should have a mid-stream urine (MSU) test before starting antibiotics. For patients with signs of acute pyelonephritis, hospital admission should be considered. Local antibiotic guidelines should be followed if available, and the BNF currently recommends a broad-spectrum cephalosporin or a quinolone (for non-pregnant women) for 7-10 days.

In summary, acute pyelonephritis is a serious condition that requires prompt diagnosis and treatment. Patients should be aware of the symptoms and seek medical attention if they experience any of the clinical features mentioned above.

Cow’s Milk and Soy Intolerance in Infants

Cow’s milk intolerance in infants can lead to anaphylactic responses, but it is more commonly associated with gastrointestinal effects and malabsorption, resulting in diarrhea. One of the most common symptoms of cow’s milk protein allergy (CMPA) is bloody stool. On the other hand, adverse reactions to soy have been reported in 10-35% of infants with CMPA. Soy may be considered as an alternative for infants over 6 months who refuse to drink extensively hydrolyzed formula and/or amino acid formula. However, soy formulations contain high concentrations of phytate, aluminum, and phytoestrogens (isoflavones), which may have undesired effects. Therefore, it is important to monitor infants for any adverse reactions when introducing soy-based formulas.

Tips for Travelling with Insulin

Many patients with diabetes experience hypoglycaemia when travelling to different time zones. To avoid this, it is recommended to reduce the total daily insulin dose by 2-4% per hour of time difference. For example, a trip to Australia may require a reduction of around 30% during the flight and the first few days of adjusting to the time difference.

When travelling with insulin, it is important to carry a membership card from the local diabetes society and a letter from the doctor to make it easier to travel with needles and syringes. Insulin should not be stored in the hold as it may freeze and form crystals. If it must be stored in the hold, it should be placed in an airtight container and packed in the middle of the suitcase. After landing, it should be checked for crystals and thrown away if any are seen.

Airline rules allow staff to store excessive needles and insulin supplies for the duration of the journey. By following these tips, patients with diabetes can travel safely and comfortably with their insulin.

Dianette has a VTE risk that is approximately 1.5-2.0 times higher than that of typical COCPs.

Co-cyprindiol (Dianette) – Updated Guidance

Co-cyprindiol, also known as Dianette, is a medication licensed for the treatment of severe acne in women who are unresponsive to prolonged oral antibacterial therapy and moderately severe hirsutism. It is also an effective contraceptive, which has contributed to its popularity. However, some post-marketing studies have shown that some women were being prescribed additional hormonal contraception alongside co-cyprindiol, which is unnecessary and increases the risk of venous thromboembolism (VTE).

The duration of co-cyprindiol treatment is limited due to concerns about VTE. Interestingly, the increased risk of VTE associated with co-cyprindiol is similar to that of combined oral contraceptive pills (COCPs) containing desogestrel, gestodene, or drospirenone, compared to COCPs containing levonorgestrel. The current evidence suggests that the VTE risk is about 1.5-2.0 times higher. Therefore, it is important to consider the risks and benefits of co-cyprindiol and other COCPs when prescribing them to women.

Calculation of Griseofulvin Dosage

When calculating the dosage of Griseofulvin for a patient, it is important to consider their weight and the recommended dose per kilogram. For example, if a patient weighs 15 kg and the recommended dose is 15 mg/kg OD, then the total dosage would be 225 mg.

Griseofulvin is available in a concentration of 125 mg in 5 ml, which means there is 25 mg in 1 ml. To determine the correct dosage, divide the total dosage (225 mg) by the concentration (25 mg/ml), which equals 9 ml. Therefore, the correct dosage for this patient would be 9 ml OD. It is important to carefully calculate and administer the correct dosage to ensure the patient receives the appropriate treatment.

Risk of QT Prolongation with Clarithromycin and Haloperidol

Both clarithromycin and haloperidol have been associated with an increased risk of QT prolongation, which can lead to potentially life-threatening arrhythmias. If a patient’s QTc interval exceeds 500 ms, it is crucial to discuss the case with the on-call team immediately. The patient may require inpatient cardiac monitoring and consultation with psychiatry regarding their current antipsychotic medication. It is essential to monitor patients closely for signs of QT prolongation when prescribing these medications and to take appropriate measures to prevent adverse outcomes. Proper management of QT prolongation can help prevent serious cardiac events and improve patient outcomes.

Monitoring Requirements for Statin Treatment

It is important to monitor patients who are undergoing statin treatment. Even if their liver function tests are normal at the beginning, they should be repeated after three months. At this point, a lipid profile should also be checked to see if the treatment targets have been achieved in terms of non-HDL cholesterol reduction. After 12 months, liver function should be checked again. If it remains normal throughout, there is no need for routine rechecking unless clinically indicated or if the statin dosage is increased. In such cases, liver function should be checked again after three months and after 12 months of the dose change.

Glitazones act as PPAR-gamma receptor agonists, which helps to decrease insulin resistance in the periphery.

Thiazolidinediones: A Class of Diabetes Medications

Thiazolidinediones are a type of medication used to treat type 2 diabetes. They work by activating the PPAR-gamma receptor, which helps to reduce insulin resistance in the body. However, one medication in this class, rosiglitazone, was withdrawn in 2010 due to concerns about its cardiovascular side effects.

The PPAR-gamma receptor is a type of nuclear receptor found inside cells. It is normally activated by free fatty acids and is involved in regulating the function and development of fat cells.

While thiazolidinediones can be effective in treating diabetes, they can also have some adverse effects. These can include weight gain, liver problems (which should be monitored with regular liver function tests), and fluid retention. Because of the risk of fluid retention, these medications are not recommended for people with heart failure. Recent studies have also suggested that there may be an increased risk of fractures and bladder cancer in people taking thiazolidinediones, particularly pioglitazone.

If there is a sensorineural issue, the sound in Weber’s test will be perceived on the healthy side (left), suggesting a problem on the affected side (right).

Rinne’s and Weber’s Test for Differentiating Conductive and Sensorineural Deafness

Rinne’s and Weber’s tests are used to differentiate between conductive and sensorineural deafness. Rinne’s test involves placing a tuning fork over the mastoid process until the sound is no longer heard, then repositioning it just over the external acoustic meatus. A positive test indicates that air conduction (AC) is better than bone conduction (BC), while a negative test indicates that BC is better than AC, suggesting conductive deafness.

Weber’s test involves placing a tuning fork in the middle of the forehead equidistant from the patient’s ears and asking the patient which side is loudest. In unilateral sensorineural deafness, sound is localized to the unaffected side, while in unilateral conductive deafness, sound is localized to the affected side.

The table below summarizes the interpretation of Rinne and Weber tests. A normal result indicates that AC is greater than BC bilaterally and the sound is midline. Conductive hearing loss is indicated by BC being greater than AC in the affected ear and AC being greater than BC in the unaffected ear, with the sound lateralizing to the affected ear. Sensorineural hearing loss is indicated by AC being greater than BC bilaterally, with the sound lateralizing to the unaffected ear.

Overall, Rinne’s and Weber’s tests are useful tools for differentiating between conductive and sensorineural deafness, allowing for appropriate management and treatment.

Reiter’s syndrome is characterized by the presence of waxy yellow papules on the palms and soles, a condition known as keratoderma blenorrhagica.

Skin Disorders Associated with Systemic Lupus Erythematosus (SLE)

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that can affect various organs and tissues in the body, including the skin. Skin manifestations of SLE include a photosensitive butterfly rash, discoid lupus, alopecia, and livedo reticularis, which is a net-like rash. The butterfly rash is a red, flat or raised rash that appears on the cheeks and bridge of the nose, often sparing the nasolabial folds. Discoid lupus is a chronic, scarring skin condition that can cause red, raised patches or plaques on the face, scalp, and other areas of the body. Alopecia is hair loss that can occur on the scalp, eyebrows, and other areas of the body. Livedo reticularis is a mottled, purplish discoloration of the skin that can occur on the arms, legs, and trunk.

The skin manifestations of SLE can vary in severity and may come and go over time. They can also be a sign of more serious internal organ involvement. Treatment for skin manifestations of SLE may include topical or oral medications, such as corticosteroids, antimalarials, and immunosuppressants, as well as sun protection measures.

Urgent Admission for a Patient with Acute Glomerulonephritis

Explanation:

A patient presenting with nephritic syndrome, including haematuria, oliguria, hypertension, and oedema, is likely suffering from acute glomerulonephritis, possibly post-streptococcal. This condition can lead to acute kidney injury and requires urgent investigation. Therefore, routine referral to paediatric nephrologists or urologists is not appropriate in this case. Instead, the patient needs to be admitted to the hospital for urgent investigation and management. While follow-up with paediatric nephrologists may be necessary, the acute presentation with hypertension and oedema requires immediate attention. A two-week rule referral for suspected malignancy is not indicated in this case.

Side-Effects of Phenytoin

Phenytoin is a medication used to treat seizures and epilepsy. However, it can have various undesirable side-effects, both in the long-term and with excessive dosage.

Acute phenytoin overdose can cause nystagmus, diplopia, slurred speech, ataxia, confusion, and hyperglycaemia. On the other hand, common side-effects not related to acute intoxication include tremors, paraesthesia, gingival hypertrophy, rashes, acne, hirsutism, and coarse facies.

In rare cases, serious haematological and neurological side-effects can occur with regular usage. Haematological side-effects include megaloblastic anaemia, aplastic anaemia, thrombocytopaenia, and agranulocytosis. Meanwhile, neurological side-effects include peripheral neuropathy and dyskinaesias.

It is important to monitor the dosage and usage of phenytoin to avoid these side-effects and ensure the patient’s safety.

To ensure that symptoms remain controlled, patients should only be prescribed theophylline by its brand name. This is due to the narrow therapeutic index of the drug and the varying release characteristics of modified-release preparations.

Prescribing Guidance for Healthcare Professionals

Prescribing medication is a crucial aspect of healthcare practice, and it is essential to follow good practice guidelines to ensure patient safety and effective treatment. The British National Formulary (BNF) provides guidance on prescribing medication, including the recommendation to prescribe drugs by their generic name, except for specific preparations where the clinical effect may differ. It is also important to avoid unnecessary decimal points when writing numbers, such as prescribing 250 ml instead of 0.25 l. Additionally, it is a legal requirement to specify the age of children under 12 on their prescription.

However, there are certain drugs that should be prescribed by their brand name, including modified release calcium channel blockers, antiepileptics, ciclosporin and tacrolimus, mesalazine, lithium, aminophylline and theophylline, methylphenidate, CFC-free formulations of beclomethasone, and dry powder inhaler devices. By following these prescribing guidelines, healthcare professionals can ensure safe and effective medication management for their patients.

Cautionary Measures When Prescribing Phosphodiesterase Type 5 Inhibitors

In clinical practice, it is important to exercise caution when prescribing phosphodiesterase type 5 inhibitors (PDE5i) in combination with nitrates. This is because the combination can lead to life-threatening hypotension due to excessive vasodilation. As such, co-prescription of PDE5i and nitrates is contraindicated.

When considering the use of PDE5i, it is important to determine whether the patient is taking nitrates regularly or as needed (PRN). Patients who are on regular daily nitrates should avoid PDE5i altogether. On the other hand, patients who use PRN nitrate medications, such as sublingual GTN spray, should avoid taking sildenafil or vardenafil within 24 hours and tadalafil within 48 hours of using the nitrate.

While recreational substances are not without their health risks, amyl nitrite, also known as poppers, is of particular concern when used with PDE5i. Amyl nitrite is a nitrite-containing compound that can have the same fatal hypotensive effect as prescribed nitrates when used in combination with PDE5i.

In summary, caution should be exercised when prescribing PDE5i in combination with nitrates, and consideration should be given to the patient’s nitrate use pattern. Patients should also be advised to avoid recreational substances, particularly amyl nitrite, when using PDE5i.

To evaluate diabetic neuropathy in the feet, it is recommended to utilize a monofilament weighing 10 grams.

Diabetic foot disease is a significant complication of diabetes mellitus that requires regular screening. In 2015, NICE published guidelines on diabetic foot disease. The disease is caused by two main factors: neuropathy, which results in a loss of protective sensation, and peripheral arterial disease, which can cause macro and microvascular ischaemia. Symptoms of diabetic foot disease include loss of sensation, absent foot pulses, reduced ankle-brachial pressure index (ABPI), intermittent claudication, calluses, ulceration, Charcot’s arthropathy, cellulitis, osteomyelitis, and gangrene.

All patients with diabetes should be screened for diabetic foot disease at least once a year. Screening for ischaemia involves palpating for both the dorsalis pedis pulse and posterial tibial artery pulse, while screening for neuropathy involves using a 10 g monofilament on various parts of the sole of the foot. NICE recommends that patients be risk-stratified into low, moderate, and high-risk categories based on factors such as deformity, previous ulceration or amputation, renal replacement therapy, and the presence of calluses or neuropathy. Patients who are moderate or high-risk should be regularly followed up by their local diabetic foot centre.

Antipsychotic Prescribing Guidelines for GPs: Consultation with Psychiatrists Recommended

Antipsychotic medication can be prescribed by GPs, but it is recommended that they consult with a psychiatrist before doing so. The drug of choice is an oral atypical antipsychotic, but prescribing doesn’t replace the need for a comprehensive multidisciplinary assessment in secondary care. A study among Irish GPs found that just over half reported prescribing antipsychotics for suspected schizophrenia, with positive symptoms being the most common reason. However, the majority always referred patients to psychiatric services. A low dose should be initiated and titrated up slowly to achieve optimum symptom control without side effects. If treatment fails, alternative atypical or low-potency first-generation antipsychotics can be considered. Recovery rates of 80% have been reported after a first episode of psychosis.

Managing Low Libido in Menopausal Women

Lubricants can provide temporary relief for menopausal women experiencing low libido, but they require frequent application and may not address the underlying issue. Measuring testosterone levels is not a reliable method for diagnosing low libido in menopausal women. While testosterone patches can benefit naturally menopausal women, they are currently only licensed for use in women who have had their ovaries removed. However, it is important to note that the postmenopausal ovary does produce testosterone. Tibolone is a medication that has been shown to improve low libido in postmenopausal women. It is important for women experiencing low libido to discuss their symptoms with their healthcare provider to determine the best course of treatment.

Treatment Guidelines for Chronic Heart Failure

Chronic heart failure is a serious condition that requires careful management. According to the NICE guidelines on Chronic heart failure (NG106), combination therapy with a beta blocker licensed for the treatment of heart failure and an ACE inhibitor is recommended. The philosophy of start low and titrate up both therapies slowly in patients with a proven reduced ejection fraction is also emphasized.

Carvedilol and bisoprolol are the two major beta blockers used for the treatment of cardiac failure, and both have well-characterized titration schedules. For second-line treatment, the addition of spironolactone at a low dose (25 mg) is recommended. In cases where patients are intolerant of both ACE inhibitors and ARBs, alternatives such as hydralazine combined with nitrate can be used.

To follow the guidelines, it is recommended to add bisoprolol 2.5 mg and titrate up the beta blocker and ramipril. By following these guidelines, patients with chronic heart failure can receive the best possible care and management.

Hepatitis A: A Self-Limiting Liver Infection

Hepatitis A is a viral infection that causes acute and self-limiting hepatitis. It is often preceded by flu-like symptoms and a brief diarrheal illness, especially in children. Unlike other forms of hepatitis, there is no chronic viral carriage or long-term liver damage associated with hepatitis A. The virus is transmitted orally and has an incubation period of 2 to 6 weeks. The most common mode of transmission is through the ingestion of contaminated food or water that has been contaminated with fecal matter from an infected person.

If a doctor has not examined the deceased within 28 days prior to their death, the case must be referred to the coroner. This time frame was extended from 14 days due to the COVID pandemic.

While it may be appropriate to list myocardial infarction as the cause of death in section 1a, the GP is not authorized to issue the death certificate in such cases. It is generally not recommended to cite old age as the cause of death.

Only a medical practitioner who is registered can complete a death certificate.

Notifiable Deaths and Reporting to the Coroner

When it comes to death certification, certain deaths are considered notifiable and should be reported to the coroner. These include unexpected or sudden deaths, as well as deaths where the attending doctor did not see the deceased within 28 days prior to their passing (this was increased from 14 days during the COVID pandemic). Additionally, deaths that occur within 24 hours of hospital admission, accidents and injuries, suicide, industrial injury or disease, deaths resulting from ill treatment, starvation, or neglect, deaths occurring during an operation or before recovery from the effect of an anaesthetic, poisoning (including from illicit drugs), stillbirths where there is doubt as to whether the child was born alive, and deaths of prisoners or people in police custody are also considered notifiable.

It is important to note that these deaths should be reported to the coroner, who will then investigate the circumstances surrounding the death. This is to ensure that any potential criminal activity or negligence is properly addressed and that the cause of death is accurately determined. By reporting notifiable deaths to the coroner, we can help ensure that justice is served and that families receive the closure they need during a difficult time.

Identifying Drug-Seeking Behavior in Patients: Signs to Look Out For

When dealing with patients, it’s important to be able to identify drug-seeking behavior. One sign to look out for is when a patient claims to be a temporary resident in the area. This is a common tactic used by drug seekers who are just passing through. However, if the patient’s parents are also your patients and they are a stable couple, this can be reassuring.

Other signs to watch for include strange smells such as cannabis, cocaine, or heroin, as well as the smell of acetone or glue on the breath. Additionally, needle tracks or difficult intravenous access may also be present. By being aware of these signs, healthcare professionals can better identify and address drug-seeking behavior in their patients.